Announcements Trials
Browse Landscape

Phase

Phase 2 79Phase 1 18Phase 1/2 13Phase 3 6Phase NA 5Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Unknown 2Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 27OTHER 6NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 5CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Non-small Cell Carcinoma 1Neoplasm, Residual 1Bronchial Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × OTHER × osimertinib × Clear all
NCT06486142 2026-05-14

ERIS

Region Skane

Phase 3 Recruiting
200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05624996 2026-05-04

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

NRG Oncology

Phase 3 Recruiting
474 enrolled
Thoracic

Lung Neoplasms

NCT04695925 2025-10-15

TOP

Sun Yat-sen University

Phase 3 Active not recruiting
294 enrolled

Non-small Cell Carcinoma

NCT06323148 2024-03-21

Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)

Fudan University

Phase 3 Not yet recruiting
226 enrolled
Thoracic

Lung Neoplasms, Neoplasm, Residual

NCT05104281 2023-03-29

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Qingdao Central Hospital

Phase 3 Unknown
60 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02972333 2016-11-23

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Shandong Cancer Hospital and Institute

Phase 3 Unknown
150 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡